Arena’s Weight-Loss Pill Poised for Approval in Obesity Fight

Arena Pharmaceuticals Inc.’s weight-loss pill gained the backing of an advisory panel, putting two obesity drugs in line for U.S. approval almost two years after regulators rejected them as too risky.